{"id":21506,"date":"2026-10-19T04:00:00","date_gmt":"2026-10-19T04:00:00","guid":{"rendered":"https:\/\/veilles-affaires-sociales.fr\/?p=21506"},"modified":"2026-10-19T04:00:00","modified_gmt":"2026-10-19T04:00:00","slug":"systeme-dechographie-diagnostiquecorrection-mise-a-jour-des-instructions-dutilisation-du-systeme-dechographie-diagnostique-lumify-de-philips-en-raison-de-problemes-lies-a","status":"publish","type":"post","link":"https:\/\/veilles-affaires-sociales.fr\/?p=21506","title":{"rendered":"Syst\u00e8me d\u2019\u00e9chographie diagnostique\nCorrection : Mise \u00e0 jour des instructions d\u2019utilisation du syst\u00e8me d\u2019\u00e9chographie diagnostique Lumify de Philips en raison de probl\u00e8mes li\u00e9s \u00e0 l\u2019\u00e9chographie Philips\u00a0(titre traduit en fran\u00e7ais par l&rsquo;IA)"},"content":{"rendered":"<p>La Food and Drug Administration (FDA) des \u00c9tats-Unis signale un rappel de type le plus s\u00e9rieux concernant certains syst\u00e8mes d\u2019\u00e9chographie diagnostique Lumify de Philips Ultrasound, utilis\u00e9 via des applications Android et iOS. Ce rappel ne porte pas sur le retrait des dispositifs du march\u00e9 ou des lieux d\u2019utilisation, mais sur une mise \u00e0 jour des instructions d\u2019utilisation. La FDA avertit que le non-respect de ces nouvelles instructions peut entra\u00eener des blessures graves ou le d\u00e9c\u00e8s.<\/p>\n<p>Sont concern\u00e9s les syst\u00e8mes Lumify Diagnostic Ultrasound System avec les versions logicielles iOS 2.X, 5.0, 5.1.2 et 5.1.3, ainsi que Android 1.X, 3.X, 4.X, 5.1 et 5.1.1, identifi\u00e9s chacun par un UDI-DI (GTIN) sp\u00e9cifique. Ces dispositifs sont utilis\u00e9s avec des sondes d\u2019\u00e9chographie connect\u00e9es \u00e0 des terminaux mobiles.<\/p>\n<p>Le 24 septembre 2026, Philips Ultrasound a adress\u00e9 un courrier \u00e0 tous les clients concern\u00e9s pour recommander des mesures d\u2019utilisation s\u00e9curis\u00e9e. Les utilisateurs sont invit\u00e9s \u00e0 n\u2019utiliser le syst\u00e8me Lumify que dans des zones o\u00f9 les signaux Wi-Fi ou cellulaires sont facilement accessibles, sauf si un autre appareil d\u2019\u00e9chographie est imm\u00e9diatement disponible en secours. Philips recommande de disposer en permanence de dispositifs ou modalit\u00e9s d\u2019\u00e9chographie de secours pour la prise en charge, de diffuser la lettre d\u2019information \u00e0 tous les utilisateurs du dispositif et d\u2019afficher un avis de mise en garde pr\u00e8s des unit\u00e9s concern\u00e9es.<\/p>\n<p>La correction fait suite \u00e0 un probl\u00e8me logiciel par lequel l\u2019application Lumify (Android ou iOS) peut ne pas reconna\u00eetre une sonde d\u00e9j\u00e0 enregistr\u00e9e et exiger une nouvelle inscription sans avertissement, juste avant un examen au point de soins. Tant que cette r\u00e9inscription n\u2019est pas r\u00e9alis\u00e9e, la fonction de balayage \u00e9chographique est bloqu\u00e9e. La proc\u00e9dure de r\u00e9inscription n\u00e9cessite un acc\u00e8s Wi-Fi ou un signal cellulaire. Le risque est jug\u00e9 particuli\u00e8rement \u00e9lev\u00e9 pour les utilisations hors h\u00f4pital (ambulances, a\u00e9ronefs, interventions de terrain), o\u00f9 l\u2019acc\u00e8s aux r\u00e9seaux est limit\u00e9. Philips indique avoir re\u00e7u des signalements de r\u00e9inscriptions impr\u00e9vues ayant emp\u00each\u00e9 la r\u00e9alisation d\u2019\u00e9chographies en pr\u00e9hospitalier et entra\u00een\u00e9 des retards de prise en charge, ces \u00e9v\u00e9nements s\u2019\u00e9tant produits en l\u2019absence de connexion r\u00e9seau. Philips pr\u00e9cise travailler au d\u00e9veloppement d\u2019une mise \u00e0 jour logicielle pour corriger ce probl\u00e8me. (contenu r\u00e9sum\u00e9 en fran\u00e7ais par l&rsquo;IA)\u00a0\u200b<a href=\"http:\/\/www.fda.gov\/medical-devices\/medical-device-recalls-and-early-alerts\/diagnostic-ultrasound-system-correction-philips-ultrasound-issues-updated-use-instructions-lumify\" target=\"_blank\" class=\"feedzy-rss-link-icon\">Lire la Suite<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>La Food and Drug Administration (FDA) des \u00c9tats-Unis signale un rappel de type le plus s\u00e9rieux concernant certains syst\u00e8mes d\u2019\u00e9chographie diagnostique Lumify de Philips Ultrasound, utilis\u00e9 via des applications Android [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":17780,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[7],"tags":[260,227,226],"class_list":["post-21506","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicaments-et-produits-de-sante","tag-fda","tag-ia","tag-sources-etrangeres"],"_links":{"self":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts\/21506","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=21506"}],"version-history":[{"count":0,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts\/21506\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/media\/17780"}],"wp:attachment":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=21506"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=21506"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=21506"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}